Estimation of drug release profiles of a heterogeneous set of drugs from a hydrophobic matrix tablet using molecular descriptors

Journal of Chemometrics

Volumn 22, Issue 11-12, 2008, Pages 653-660

  Matero, Sanni ^a   Reinikainen, Satu Pia ^b   Lahtela Kakkonen, Maija ^a   Korhonen, Ossi ^a   Ketolainen, Jarkko ^a   Poso, Antti ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b LAPPEENRANTA UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Drug release; Matrix tablet; Multivariate data analysis; PLS; VolSurf descriptors

Indexed keywords

DISSOLUTION; DRUG PRODUCTS; MULTIVARIANT ANALYSIS; TARGETED DRUG DELIVERY;

DESCRIPTORS; DISSOLUTION PROFILES; DRUG RELEASE; MATRIX TABLET; MOLECULAR DESCRIPTORS; MULTIVARIATE DATA ANALYSIS; PLS; RELEASE PROFILES; VOLSURF; VOLSURF DESCRIPTOR;

CONTROLLED DRUG DELIVERY;

EID: 57149114136     PISSN: 08869383     EISSN: 1099128X     Source Type: Journal    
DOI: 10.1002/cem.1148     Document Type: Conference Paper

References (30)

1. Lee V, Yang J. Oral drug delivery. In Drug Delivery and Targeting for Pharmacists and Pharmaceutical Scientists, vol. 1. Taylor & Francis: London and New York, 2001; 146-184.
2. Wise DL (ed). Handbook of Pharmaceutical Controlled Release Technology, vol. 1. Marcel Dekker, Inc.: New York and Basel, 2000; 1, 163.
3. Varma MVS, Kaushal AM, Garg A, Garg S. Factors affecting mechanism and kinetics of drug release from matrix-based oral controlled drug delivery systems. Am. J. Drug Deliv. 2004; 2: 43-57.
4. Alderborn G, Nyström C (eds). Pharmaceutical powder compaction technology, Vol. I. Marcel Dekker, Inc.: New York, 1996; 7-9, 17-18, 419.
5. Grassi M, Grassi G. Mathematical modelling and controlled drug delivery: matrix systems. Curr. Drug Deliv. 2005; 2: 97-116.
6. Kanjickal DG, Lopina ST. Modelling of drug release from polymeric delivery systems - A review. Crit. Rev. Ther. Drug 2004; 21: 345-386.
7. Aulton ME (ed). Pharmaceutics: The Science of Dosage Form Designs. Vol. 2. Churchill Livingstone: Philadelphia 2002; 2.
8. Costa FO, Sousa JJ, Pais AA, Formosinho SJ. Comparison of dissolution profiles of Ibuprofen pellets. J. Control. Release 2003; 89: 199-212.
9. Adams E, De Maesschalck R, De Spiegeleer B, Vander Heyden Y, Smeyers-Verbeke J, Massart DL. Evaluation of dissolution profiles using principal component analysis. Int. J. Pharm. 2001; 212: 41-53.
10. Costa P, Manuel J, Lobo S. Modelling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001; 13: 123-133.
11. Siepmann J, Peppas NA. Mathematical modelling of controlled drug delivery. Adv. Drug Deliv. Rev. 2001; 48: 137-138.
12. Siepmann J, Peppas NA. Modelling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 2001; 48: 139-157.
13. Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963; 52: 1145-1149.
14. Cruciani G, Pastor M, Guba W. Volsurf: a new tool for the pharmacokinetic optimization of lead compounds. Eur. J. Pharm. Sci. 2000; 11: S29-S39.
15. Matero S, Lahtela-Kakkonen M, Korhonen O, Ketolainen J, Lappalainen R, Poso A. Chemical space of orally active compounds. Chemom. Intell. Lab. Syst. 2006; 84: 134-141.
16. Crivori P, Cruciani G, Carrupt PA, Testa B. Predicting blood-brain barrier permeation from three-dimensional molecular structure. J. Med. Chem. 2000; 43: 2204-2216.
17. Cruciani G (ed). Molecular Interaction Fields, Vol. I. WILEY-VCH Verlag GmbH & Co.: Weinheim, 2006; 173-194.
18. van Veen B, Pajander J, Zuurman K, Lappalainen R, Poso A, Frijlink HW, Ketolainen J. The effect of powder blend and tablet structure on drug release mechanisms of hydrophobic starch acetate matrix tablets. Eur. J. Pharm. Biopharm. 2005; 61: 149-157.
19. Korhonen O, Matero S, Poso A, Ketolainen J. Partial least square projections to latent structure analysis (PLS) in evaluating and predicting drug release from starch acetate matrix tablets. J. Pharm. Sci. 2005; 94: 2716-2730.
20. Pohja S, Suihko E, Vidgren M, Paronen P, Ketolainen J. Starch acetate as a tablet matrix for sustained drug release. J. Control. Release 2004; 94: 293-302.
21. Ferrero C, Bravo I, Jimenez-Castellanos MR. Drug release kinetics and fronts movement studies from methyl methacrylate (MMA) copolymer matrix tablets: effect of copolymer type and matrix porosity. J. Control. Release 2003; 92: 69-82.
22. Korhonen O, Raatikainen P, Harjunen P, Nakari J, Suihko E, Peltonen S, Vidgren M, Paronen P. Starch acetates - multifunctional direct compression excipients. Pharm. Res. 2000; 17: 1138-1143.
23. VolSurf 4.1.4, Molecular Discovery Ltd., 215 Marsh Road, 1st Floor, HA5 5NE, Pinner, Middlesex, UK http://www.moldiscovery.com/soft_volsurf. php/ [4 October 2007].
24. Clarke' s Analysis of Drugs and Poisons http://www. medicinescomplete.com/mc/clarke/current/ [4 October 2007].
25. Paakkunainen M, Matero S, Ketolainen J, Lahtela-Kakkonen M, Poso A, Reinikainen SP. Dissolution test of drug release: uncertainty measurements. Submitted to Chemometr. Intell. Lab.
26. Höskuldsson A. Prediction Methods in Science and Technology, vol. 1. Thor Publishing: Copenhagen, 1996; 327-330.
27. PLS_toolbox4.0, Eigenvector Research Inc., 3905 West Eaglerock Drive, Wenatchee. WA 98801 http://software.eigenvector.com/ [4 October 2007].
28. Matlab7.0, The MathWorks Inc., 3 Apple Hill Drive, Natick, MA 017602098, USA http://www.mathworks.com/ [4 October 2007].
29. Pajander J, van Veen B, Korhonen O, Lappalainen R, Ketolainen J. Liquid boundary movements in cylindrical and convex hydrophobic matrix tablets: effects on tablet cracking and drug release. Eur. J. Pharm. Biopharm. 2006; 64: 167-172.
30. van der Voort Maarschalk K, Zuurman K, Vromans H, Bolhuis GK, Lerk CF. Porosity expansion of tablets as a result of bonding and deformation of particulate solids. Int. J. Pharm. 1996; 140: 185-193.